In summary, enhanced inflammasome activation driven by molecular and genetic factors highlights important aspects of fatal COVID-19 in the second wave, highlighting IL-18 and related genetic markers (rs4648090 NFKB1 and rs317155 NOX4) as molecules of key interest for prognostic and therapeutic consideration in future severe respiratory diseases. The gene discussed is IL18; the disease is respiratory system disorder.